Camber Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300,000	Closed	-$28.1M	–	45
2022 Q1	$28.1M	Buy	+300,000	New	+$28.1M	1.02%	25